Pall Corporation engages in manufacturing and marketing filtration, purification, and separation products and integrated systems solutions worldwide. The companyís Life Sciences segment provides technologies that facilitate the process of drug discovery, development, regulatory validation, and production used in the research laboratories, pharmaceutical, biotechnology, and food and beverage industries, as well as in hospitals at the point of patient care. It offers medical products to control the spread of infections in hospitals; cell therapy products that enable technologies for the regenerative medicine market; and various filtration and purification technologies, appurtenant hardware, and engineered systems for the development and commercialization of chemically synthesized and biologically derived drugs, plasma, and vaccines, as well as offers filtration solutions. This segment also provides validation services to drug manufacturers; laboratory products for use in drug research and discovery, quality control testing, and environmental monitoring applications; and serves the filtration needs of beer, wine, dairy, alcohol-free beverage, bottled water, and food ingredient markets. Pall Corporationís Industrial segment provides various technologies to producers of energy, oil, gas, renewable and alternative fuels, electricity, chemicals, and municipal water; and filtration solutions to the machinery and equipment markets, This segment also offers filtration and fluid monitoring equipment for use on commercial and military aircraft, ships, and land-based military vehicles in the aerospace industry; filtration and purification technologies for the semiconductor, data storage, fiber optic, advanced display, solar, and materials markets; and a suite of contamination control solutions for chemical, gas, water, chemical mechanical polishing, and photolithography processes. The company was founded in 1946 and is headquartered in Port Washington, New York.